Trial Details
COMPLETEDBasic Information
| Clinical ID | c1470 |
|---|---|
| Identifier | NCT02065622 |
| Trial Title | Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis (UC) |
| Interventions | DRUG: Adalimumab|OTHER: Placebo |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | Dothan |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2014-03-27 |
|---|---|
| Primary Completion Date | 2019-09-05 |
| Completion Date | 2019-11-11 |